Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Phosphorylated STAT5 directly facilitates parvovirus B19 DNA replication in human erythroid progenitors through interaction with the MCM complex.

Ganaie SS, Zou W, Xu P, Deng X, Kleiboeker S, Qiu J.

PLoS Pathog. 2017 May 1;13(5):e1006370. doi: 10.1371/journal.ppat.1006370. eCollection 2017 May.

2.

STAT3 activation in infection and infection-associated cancer.

Lu R, Zhang YG, Sun J.

Mol Cell Endocrinol. 2017 Aug 15;451:80-87. doi: 10.1016/j.mce.2017.02.023. Epub 2017 Feb 20.

PMID:
28223148
3.

Chronic Inhibition of STAT3/STAT5 in Treatment-Resistant Human Breast Cancer Cell Subtypes: Convergence on the ROS/SUMO Pathway and Its Effects on xCT Expression and System xc- Activity.

Linher-Melville K, Nashed MG, Ungard RG, Haftchenary S, Rosa DA, Gunning PT, Singh G.

PLoS One. 2016 Aug 11;11(8):e0161202. doi: 10.1371/journal.pone.0161202. eCollection 2016.

4.

Interleukin-2 Receptor β Thr-450 Phosphorylation Is a Positive Regulator for Receptor Complex Stability and Activation of Signaling Molecules.

Ruiz-Medina BE, Ross JA, Kirken RA.

J Biol Chem. 2015 Aug 21;290(34):20972-83. doi: 10.1074/jbc.M115.660654. Epub 2015 Jul 7.

5.

Orphan nuclear receptor small heterodimer partner negatively regulates growth hormone-mediated induction of hepatic gluconeogenesis through inhibition of signal transducer and activator of transcription 5 (STAT5) transactivation.

Kim YD, Li T, Ahn SW, Kim DK, Lee JM, Hwang SL, Kim YH, Lee CH, Lee IK, Chiang JY, Choi HS.

J Biol Chem. 2012 Oct 26;287(44):37098-108. doi: 10.1074/jbc.M112.339887. Epub 2012 Sep 12.

6.

Phosphoproteomic analysis of leukemia cells under basal and drug-treated conditions identifies markers of kinase pathway activation and mechanisms of resistance.

Alcolea MP, Casado P, Rodríguez-Prados JC, Vanhaesebroeck B, Cutillas PR.

Mol Cell Proteomics. 2012 Aug;11(8):453-66. doi: 10.1074/mcp.M112.017483. Epub 2012 Apr 29.

7.

Dynamics of the G protein-coupled vasopressin V2 receptor signaling network revealed by quantitative phosphoproteomics.

Hoffert JD, Pisitkun T, Saeed F, Song JH, Chou CL, Knepper MA.

Mol Cell Proteomics. 2012 Feb;11(2):M111.014613. doi: 10.1074/mcp.M111.014613. Epub 2011 Nov 21.

8.

The tumor suppressor hTid1 inhibits STAT5b activity via functional interaction.

Dhennin-Duthille I, Nyga R, Yahiaoui S, Gouilleux-Gruart V, Régnier A, Lassoued K, Gouilleux F.

J Biol Chem. 2011 Feb 18;286(7):5034-42. doi: 10.1074/jbc.M110.155903. Epub 2010 Nov 24.

9.
10.

Gamma c-signaling cytokines induce a regulatory T cell phenotype in malignant CD4+ T lymphocytes.

Kasprzycka M, Zhang Q, Witkiewicz A, Marzec M, Potoczek M, Liu X, Wang HY, Milone M, Basu S, Mauger J, Choi JK, Abrams JT, Hou JS, Rook AH, Vonderheid E, Woetmann A, Odum N, Wasik MA.

J Immunol. 2008 Aug 15;181(4):2506-12.

11.

Reaction-diffusion modeling ERK- and STAT-interaction dynamics.

Georgiev N, Petrov V, Georgiev G.

EURASIP J Bioinform Syst Biol. 2006:85759. doi: 10.1155/BSB/2006/85759.

12.

Indirect genomic effects on survival from gene expression data.

Ferkingstad E, Frigessi A, Lyng H.

Genome Biol. 2008;9(3):R58. doi: 10.1186/gb-2008-9-3-r58. Epub 2008 Mar 22.

13.

Estrogen and progesterone are critical regulators of Stat5a expression in the mouse mammary gland.

Santos SJ, Haslam SZ, Conrad SE.

Endocrinology. 2008 Jan;149(1):329-38. Epub 2007 Sep 20.

14.

Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter.

Nyga R, Pecquet C, Harir N, Gu H, Dhennin-Duthille I, Régnier A, Gouilleux-Gruart V, Lassoued K, Gouilleux F.

Biochem J. 2005 Aug 15;390(Pt 1):359-66.

Supplemental Content

Support Center